Talk:5-HT2C receptor agonist

This is the talk page for discussing improvements to the 5-HT2C receptor agonist article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Articles for creation

	This article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.Articles for creationWikipedia:WikiProject Articles for creationTemplate:WikiProject Articles for creationAfC articles
	This article was accepted on 2 October 2012 by reviewer Alanl (talk · contribs).

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Copy edit for style?

Responding to this note. This article is very technical, but the style seems okay. I've seen much worse.

Would someone care to clarify? Kortoso (talk) 22:22, 28 October 2015 (UTC)[reply]

Mechanism Section Technical Flag

The Mechanism section of this article could be improved for the general Wikipedia audience. While scientists with some biology background may be able to understand this section, the average reader is likely to struggle. Is it possible to rewrite this section, streamlining to focus on agonist mechanism of action, with a much simpler, minimalist description of only the relevant (to agonist action) receptor/receptor mechanism of action biology? The receptor composition, mechanism of action, etc. details are covered in linked articles. Laatu (talk) 16:10, 9 January 2016 (UTC)[reply]

Request for Update

Regarding: As of 2012, Vabicaserin is in clinical trials for the treatment of schizophrenia. Does anyone know the outcome of those trials & if so, could you please update this section (with references)? Thank you. Laatu (talk) 16:53, 9 January 2016 (UTC)[reply]